112 related articles for article (PubMed ID: 3455067)
1. Inhibition of thrombin-induced platelet aggregation by high molecular weight kininogen.
Puri RN; Gustafson EJ; Zhou FX; Bradford H; Colman RF; Colman RW
Trans Assoc Am Physicians; 1987; 100():232-40. PubMed ID: 3455067
[TBL] [Abstract][Full Text] [Related]
2. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
[TBL] [Abstract][Full Text] [Related]
3. Plasmin-induced platelet aggregation is accompanied by cleavage of aggregin and indirectly mediated by calpain.
Puri RN; Zhou FX; Colman RF; Colman RW
Am J Physiol; 1990 Dec; 259(6 Pt 1):C862-8. PubMed ID: 2148055
[TBL] [Abstract][Full Text] [Related]
4. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW
Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of a kininogen-based selective inhibitor of thrombin-induced platelet aggregation.
Matsueda R; Umeyama H; Puri RN; Bradford HN; Colman RW
Pept Res; 1994; 7(1):32-5. PubMed ID: 8019060
[TBL] [Abstract][Full Text] [Related]
6. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets.
Puri RN; Zhou F; Hu CJ; Colman RF; Colman RW
Blood; 1991 Feb; 77(3):500-7. PubMed ID: 1846761
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of thrombin- and plasmin-induced platelet aggregation by a synthetic peptide disulfide.
Puri RN; Hu CJ; Bradford HN; Matsueda R; Umeyama H; Colman RW
Trans Assoc Am Physicians; 1989; 102():13-9. PubMed ID: 2561638
[TBL] [Abstract][Full Text] [Related]
8. gammaA/gamma' fibrinogen inhibits thrombin-induced platelet aggregation.
Lovely RS; Rein CM; White TC; Jouihan SA; Boshkov LK; Bakke AC; McCarty OJ; Farrell DH
Thromb Haemost; 2008 Nov; 100(5):837-46. PubMed ID: 18989528
[TBL] [Abstract][Full Text] [Related]
9. High molecular weight kininogen is an inhibitor of platelet calpain.
Schmaier AH; Bradford H; Silver LD; Farber A; Scott CF; Schutsky D; Colman RW
J Clin Invest; 1986 May; 77(5):1565-73. PubMed ID: 2422211
[TBL] [Abstract][Full Text] [Related]
10. Aggregin: a platelet ADP receptor that mediates activation.
Colman RW
FASEB J; 1990 Mar; 4(5):1425-35. PubMed ID: 2407587
[TBL] [Abstract][Full Text] [Related]
11. Reocclusion after thrombolytic therapy: strategies for inhibiting thrombin-induced platelet aggregation.
Puri RN; Colman RW
Blood Coagul Fibrinolysis; 1993 Jun; 4(3):465-78. PubMed ID: 8329574
[TBL] [Abstract][Full Text] [Related]
12. Cleavage of a 100 kDa membrane protein (aggregin) during thrombin-induced platelet aggregation is mediated by the high affinity thrombin receptors.
Puri RN; Zhou FX; Colman RF; Colman RW
Biochem Biophys Res Commun; 1989 Aug; 162(3):1017-24. PubMed ID: 2475104
[TBL] [Abstract][Full Text] [Related]
13. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
14. Contribution of PAR-1, PAR-4 and GPIbalpha in intracellular signaling leading to the cleavage of the beta3 cytoplasmic domain during thrombin-induced platelet aggregation.
Dubois C; Steiner B; Meyer Reigner SC
Thromb Haemost; 2004 Apr; 91(4):733-42. PubMed ID: 15045135
[TBL] [Abstract][Full Text] [Related]
15. Functional involvement of thrombospondin in platelet aggregation induced by low versus high concentrations of thrombin.
Kao KJ; Shaut DM; Klein PA
Thromb Haemost; 1986 Feb; 55(1):136-42. PubMed ID: 3705001
[TBL] [Abstract][Full Text] [Related]
16. Vinculin is proteolyzed by calpain during platelet aggregation: 95 kDa cleavage fragment associates with the platelet cytoskeleton.
Serrano K; Devine DV
Cell Motil Cytoskeleton; 2004 Aug; 58(4):242-52. PubMed ID: 15236355
[TBL] [Abstract][Full Text] [Related]
17. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A
Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
[TBL] [Abstract][Full Text] [Related]
19. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
España F; Ratnoff OD
J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
[TBL] [Abstract][Full Text] [Related]
20. Aggregin: the platelet receptor mediating activation by ADP.
Colman RW; Puri RN; Zhou FX; Colman RF
Prog Clin Biol Res; 1988; 283():263-77. PubMed ID: 3211953
[No Abstract] [Full Text] [Related]
[Next] [New Search]
